CHANGE IN IMMUNOLOGICAL MEMORY OF HEPATITIS B VACCINE AFTER CHEMOTHERAPY; A REAL PROBLEM IN PEDIATRIC CANCER PATIENTS.
- Pediatrics, Faculty of Medicine, Zagazig University, Egypt.
- Clinical Pathology Departments, Faculty of Medicine, Zagazig University, Egypt.
- Cite This Article as
- Corresponding Author
Background:-Children with cancer are at risk of Hepatitis B virus infections as a result of recurrent blood transfusions and also due to suppressed immune system. The national immunization program plays an important role in decreasing hepatitis B infection in children with cancer; however, the efficacy of the immunization strategies is questionable. We aimed at evaluating the acquired immunity from previous hepatitis B vaccination in cancer patients after recovery of their immune system. Patients and Methods:- Case control study was conducted on 22 patients with cancer(13 males,9 females, mean age 7.2±3.14 years) who completed their standard chemotherapy at least 6 months prior to the study. Twenty two age and sex matched healthy children were enrolled as a control group. HBsAb and HBcAb concentrations were determined in the studied subject\'s serum by ELISA. Results:- The frequency of non immune subjects in children with cancer was significantly higher than those in healthy children (P-value=0.001), where anti-HBs antibody titer was more than 10 mIU/ml in 54.5% of patients and less than 10 mIU/ml in 45.5% of patients. While in healthy controls, 90.9% had antibody titer more than10 mIU/ml and 9.1% had antibody titer less than 10mIU/ml. No significant relation was found between loss of immunity against HBV and age of patient, type of cancer and duration of chemotherapy. Conclusion:-Children with cancer are at increased risk for HBV infection. HBV revaccination should be considered at least six month post chemotherapy.
[Ahmed G El Akhras, Mervat A Mohamed, Manal M AI Amin, Marwa Zakaria, Mohamed R Beshir, Wesam A Mokhtar, Sherief M El gebaly and Atef MM Khalil. (2016); CHANGE IN IMMUNOLOGICAL MEMORY OF HEPATITIS B VACCINE AFTER CHEMOTHERAPY; A REAL PROBLEM IN PEDIATRIC CANCER PATIENTS. Int. J. of Adv. Res. 4 (7). 2106-2110] (ISSN 2320-5407). www.journalijar.com
Article DOI: 10.21474/IJAR01/1099 DOI URL: http://dx.doi.org/10.21474/IJAR01/1099
Share this article
This work is licensed under a Creative Commons Attribution 4.0 International License.